Charles Bond, MD
Orthopaedic Surgery · Rutherfordton, NCNPI 1467448282
Payments from drug & device makers
Across 50 payments — averaging $20.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Therapeutics, Inc.$200
- Baudax Bio Inc.$160
- Smith+Nephew$113
- Peerless Surgical Inc.$103
- Endo Pharmaceuticals Inc.$70
- Sanofi-aventis U.S. LLC$69
- plus $335 from 12 others
What the payments were for
- Food & beverage$1,050100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Therapeutics, Inc. | 9 | $200 |
| Baudax Bio Inc. | 8 | $160 |
| Smith+Nephew | 4 | $113 |
| Peerless Surgical Inc. | 3 | $103 |
| Endo Pharmaceuticals Inc. | 5 | $70 |
| Sanofi-aventis U.S. LLC | 3 | $69 |
| Bioventus LLC | 4 | $66 |
| Vertex | 2 | $53 |
| Nevro Corp. | 2 | $43 |
| Zimmer Biomet | 2 | $25 |
| Heron Therapeutics, Inc. | 1 | $25 |
| Davol Inc. | 1 | $24 |
| Inari Medical, Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Stryker | 1 | $15 |
| DJO, LLC | 1 | $13 |
How this compares
$1,050 in reported general payments places this provider in the 20th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 123 | $2,551 |
| Meloxicam | 742 | $1,910 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 177 | $1,609 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 112 | $858 |
| Tizanidine Hcl | 47 | $667 |
| Methylprednisolone | 56 | $288 |
| Cyclobenzaprine Hcl | 67 | $271 |
| Tramadol Hcl | 95 | $264 |
| Naproxen | 26 | $244 |
| Gabapentin | 23 | $158 |
| Cephalexin | 42 | $99 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Rutherfordton
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$6.2M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$5.2M
- Mark EasleyDurham$4.2M
- Carroll JonesCharlotte$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.